G01N 2333/8128
Antithrombin iii
Official title: Antithrombin III
G01N2333/8128 (Antithrombin iii) appears on 46 US grants and 25 published applications in this corpus.
Search patents in G01N- Granted patents
- 46
- Published applications
- 25
- Assignees
- 38
- Inventors
- 121
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 0 | 0 |
| 2018 | 2 | 2 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 3 |
| 2023 | 1 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aptamer based system to quantify anti-thrombin III in blood26 May 2026US 12,637,679 B2University of Florida Research Foundation, Inc.
- Biomarkers of vascular disease21 Nov 2023US 11,821,905 B2Arterez, Inc.
- Reagent and method for measuring thrombin-antithrombin complex5 Jul 2022US 11,378,577 B2Lsi Medience Corporation
- Biomarkers of vascular disease12 Oct 2021US 11,143,659 B2Arterez, Inc.
- Pre-treatment agent and pre-treatment method for antithrombin III to be subjected to limulus test20 Nov 2018US 10,132,812 B2Seikagaku Corporation
- Factor xa reagent25 Dec 2025US 2025/0389737 A1Instrumentation Laboratory Company
- Point of care testing system for antithrombin iii6 Mar 2025US 2025/0076264 A1University of Florida Research Foundation, Inc.
- A method to identify lvad patients with elevated levels of blood activation using coupon tests22 Feb 2024US 2024/0060998 A1Medtronic, Inc.
- Antithrombin heparan sulfate for detection and treatment of cancer15 Feb 2024US 2024/0053342 A1The Regents of the University of California
- Treatment of hemophilia with fitusiran25 Jan 2024US 2024/0027478 A1Genzyme Corporation
Most cited
By later US patents
- Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups478US 6,121,027 ASurModics, Inc. · 2000
- Polybifunctional reagent having a polymeric backbone and latent reactive moieties and bioactive groups59US 6,514,734 B1SurModics, Inc. · 2003
- Mucopolysaccharides having biological properties, preparation and method of use46US 4,500,519 AChoay S. A. · 1985
- Test for the detection of anti-heparin antibodies35US 5,753,445 AThe Mount Sinai Medical Center of the City University of New York · 1998
- Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation33US 4,692,435 AChoay S. A. · 1987